Immunohistochemical Determination of Primary Sites of Carcinomas

References

• Howarth DJ, Aronson IB, Diamandis EP: Immunohistochem-ical localization of prostate-specific antigen in benign and malignant breast tissues. Br J Cancer 75:1646–51, 1997
   PubMed Web of Science ®Google Scholar
• Gabbiani G, Kapanci Y, Barazzone P et al: Immunochemical identification of intermediate-sized filaments in human neo-plastic cells. A diagnostic aid for the surgical pathologist. Am J Pathol 104:206–216, 1981
   PubMed Web of Science ®Google Scholar
• Moll R, Lowe A, Laufer J, Franke WW: Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427–47, 1992
   PubMed Web of Science ®Google Scholar
• Quinlan RA, Schiller DL, Hatzfeld M et al: Patterns of ex-pression and organization of cytokeratin intermediate fila-ments. Ann N Y Acad Sci 455:282–306, 1985
   PubMed Web of Science ®Google Scholar
• Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT: Im-munolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 95:580–8, 1982
   PubMed Web of Science ®Google Scholar
• Gown AM, Vogel AM: Monoclonal antibodies to human in-termediate filament proteins. II. Distribution of filament pro-teins in normal human tissues. Am J Pathol 114:309–21, 1984
   PubMed Web of Science ®Google Scholar
• Gown AM, Vogel AM: Monoclonal antibodies to human in-termediate filament proteins. III. Analysis of tumors. Am J Clin Pathol 84:413–24, 1985
   PubMed Web of Science ®Google Scholar
• van-Niekerk CC, Jap PH, Ramaekers FC et al: Immunohisto-chemical demonstration of keratin 7 in routinely fixed paraf-fin-embedded human tissues. J Pathol 165:145–52, 1991
   PubMedGoogle Scholar
• Ramaekers F, van-Niekerk C, Poels L et al: Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 136:641–55, 1990
   PubMed Web of Science ®Google Scholar
• Ueda G, Sawada M, Ogawa H et al: Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adeno-carcinomas in the ovary. Gynecol Oncol 51:219–23, 1993
   PubMed Web of Science ®Google Scholar
• Guerrieri C, Franlund B, Boeryd B: Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix. Mod Pathol 8:573–6, 1995
   PubMed Web of Science ®Google Scholar
• Ascoli V, Taccogna S, Scalzo CC, Nardi F: Utility of cyto-keratin 20 in identifying the origin of metastatic carcinomas in effusions. Diagn Cytopathol 12:303–8, 1995
   PubMed Web of Science ®Google Scholar
• Loy TS, Calaluce RD: Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic ad-enocarcinomas. Am J Clin Pathol 102:764–67, 1994
   PubMed Web of Science ®Google Scholar
• Wang NP, Bacchi CE, Gown AM: Coordinate expression of cytokeratins 7 and 20 define unique subsets of carcinomas. Appl Immunohistochem 3:99–107, 1995
   Google Scholar
• Berezowski K, Stastny JF, Kornstein MJ: Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic car-cinoma. Mod Pathol 9:426–9, 1996
   PubMed Web of Science ®Google Scholar
• Loy TS, Calaluce RD, Keeney GL: Cytokeratin immunostain-ing in differentiating primary ovarian carcinoma from meta-static colonic adenocarcinoma. Mod Pathol 9:1040–4, 1996
   PubMed Web of Science ®Google Scholar
• Ronnett BM, Kurman RJ, Shmookler BM et al: The morpho-logic spectrum of ovarian metastases of appendiceal adeno-carcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 21:1144–55, 1997
   PubMed Web of Science ®Google Scholar
• Ordonez N: Value of cytokeratin 5/6 immunostaining in dis-tinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 22:1215–1221, 1998
   PubMed Web of Science ®Google Scholar
• Clover J, Oates J, Edwards C: Anti-cytokeratin 5/6: a positive marker for epithelioid mesothelioma. Histopathology 31:140–3, 1997
   PubMed Web of Science ®Google Scholar
• Wagener C, Hain F, Breuer H et al: Immunohistochemical demonstration of carcinoembryonic antigen in normal, transi-tional and inflamed colonic mucosa. Oncodev Biol Med 2: 331–43, 1981
   PubMedGoogle Scholar
• Sanders DS, Evans AT, Allen CA et al: Classification of CEA-related positivity in primary and metastatic malignant mela-noma. J Pathol 172:343–8, 1994
   PubMed Web of Science ®Google Scholar
• Selby WL, Nance KV, Park HK: CEA immunoreactivity in metastatic malignant melanoma. Mod Pathol 5:415–9, 1992
   PubMed Web of Science ®Google Scholar
• Ben-Izhak O, Stark P, Levy R et al: Epithelial markers in malignant melanoma. A study of primary lesions and their metastases. Am J Dermatopathol 16:241–6, 1994
   PubMed Web of Science ®Google Scholar
• Watt SM, Sala-Newby G, Hoang T et al: CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules. Blood 78:63–74, 1991
   PubMed Web of Science ®Google Scholar
• Grunert F, Daniel S, Nagel G et al: CD66b, CD66c and car-cinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients. Int J Cancer 63:349–55, 1995
   PubMed Web of Science ®Google Scholar
• Murakami M, Kuroki M, Arakawa F et al: A reference of the GOLD classification of monoclonal antibodies against car-cinoembryonic antigen to the domain structure of the carcino-embryonic antigen molecule. Hybridoma 14:19–28, 1995
   PubMed Web of Science ®Google Scholar
• Tsutsumi Y, Nagura H, Watanabe K: Immunohistochemical observations of carcinoembryonic antigen (CEA) and CEA-related substances in normal and neoplastic pancreas. Pitfalls and caveats in CEA immunohistochemistry. Am J Clin Pathol 82:535–42, 1984
   PubMed Web of Science ®Google Scholar
• Larsson A, Ghosh R, Hammarstrom S: Relative positions of some epitopes on carcinoembryonic antigen. Cancer Immunol Immunother 30:92–6, 1989
   PubMed Web of Science ®Google Scholar
• Waldherr R, Schwechheimer K: Co-expression of cytokeratin and vimentin intermediate-sized filaments in renal cell carci-nomas. Comparative study of the intermediate-sized filament distribution in renal cell carcinomas and normal human kid-ney. Virchows Arch A Pathol Anat Histopathol 408:15–27, 1985
   PubMedGoogle Scholar
• Beham A, Ratschek M, Zatloukal K et al: Distribution of cytokeratins, vimentin and desmoplakins in normal renal tis-sue, renal cell carcinomas and oncocytoma as revealed by immunofluorescence microscopy. Virchows Arch A Pathol Anat Histopathol 421:209–15, 1992
   PubMedGoogle Scholar
• Churg A: Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol 9:360–5, 1985
   PubMed Web of Science ®Google Scholar
• Gould VE, Koukoulis GK, Jansson DS et al: Coexpression patterns of vimentin and glial filament protein with cytoker-atins in the normal, hyPerplastic, and neoplastic breast. Am J Pathol 137:1143–55, 1990
   PubMed Web of Science ®Google Scholar
• Raymond WA, Leong AS: Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neo-plastic breast epithelium. J Pathol 157:299–306, 1989
   PubMed Web of Science ®Google Scholar
• Domagala W, Lasota J, Bartkowiak J et al: Vimentin is pref-erentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol 136:219–27, 1990
   PubMed Web of Science ®Google Scholar
• Nadji M, Tabei SZ, Castro A et al: Prostatic origin of tumors. An immunohistochemical study. Am J Clin Pathol 73:735–9, 1980
   PubMed Web of Science ®Google Scholar
• Nadji M, Tabei SZ, Castro A et al: Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer 48:1229–32, 1981
   PubMed Web of Science ®Google Scholar
• Azumi N, Traweek ST, Battifora H: Prostatic acid phospha-tase in carcinoid tumors. Immunohistochemical and immuno-blot studies [see comments]. Am J Surg Pathol 15:785–90, 1991
   PubMed Web of Science ®Google Scholar
• Albores-Saavedra J, Nadji M, Civantos F, Morales AR: Thy-roglobulin in carcinoma of the thyroid: an immunohistochem-ical study. Hum Pathol 14:62–6, 1983
   PubMed Web of Science ®Google Scholar
• Franklin WA, Mariotti S, Kaplan D, DeGroot LJ: Immuno-fluorescence localization of thyroglobulin in metastatic thy-roid cancer. Cancer 50:939–45, 1982
   PubMed Web of Science ®Google Scholar
• Fabbro D, Di L-C, Beltrami CA et al: Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thy-roid neoplasms. Cancer Res 54:4744–9, 1994
   PubMed Web of Science ®Google Scholar
• Mazoujian G, Pinkus GS, Davis S, Haagensen DE Jr: Immu-nohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol 110:105–12, 1983
   PubMed Web of Science ®Google Scholar
• Wick MR, Lillemoe TJ, Copland GT et al: Gross cystic dis-ease fluid protein-15 as a marker for breast cancer: immuno-histochemical analysis of 690 human neoplasms and compari-son with alpha-lactalbumin. Hum Pathol 20:281–7, 1989
   PubMed Web of Science ®Google Scholar
• Chang K, Pai LH, Batra JK et al: Characterization of the antigen (CAK1) recognized by monoclonal antibody K 1 pres-ent on ovarian cancers and normal mesothelium. Cancer Res 52:181–6, 1992
   PubMed Web of Science ®Google Scholar
• Chang K, Pastan I: Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line. Int J Cancer 57: 90–7, 1994
   PubMed Web of Science ®Google Scholar
• Chang K, Pai LH, Pass H et al: Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adeno-carcinoma. Am J Surg Pathol 16:259–68, 1992
   PubMed Web of Science ®Google Scholar
• Guazzi S, Price M, De Felice M et al: Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. Embo J 9:3631–9, 1990
   PubMed Web of Science ®Google Scholar
• Lazzaro D, Price M, de Felice M, Di Lauro R: The transcrip-tion factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 113:1093–104, 1991
   PubMed Web of Science ®Google Scholar
• Bohinski RJ, Di Lauro R, Whitsett JA: The lung-specific sur-factant protein B gene promoter is a target for thyroid tran-scription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 14:5671–81, 1994
   PubMed Web of Science ®Google Scholar
• Bohinski RJ, Huffman JA, Whitsett JA, Lattier DL: Cis-active elements controlling lung cell-specific expression of human pulmonary surfactant protein B gene. J Biol Chem 268:11160–6, 1993
   PubMed Web of Science ®Google Scholar
• Bejarano PA, Baughman RP, Biddinger PW et al: Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol 9:445–52, 1996
   PubMed Web of Science ®Google Scholar
• Fabbro D, Di L-C, Stamen-a 0 et al: TTF-1 gene expression in human lung tumors. Eur J Cancer 3:512–7, 1996
   Google Scholar
• Holzinger A, Dingle S, Bejarano PA et al: Monoclonal anti-body to thyroid transcription factor-1: production, character-ization, and usefulness in tumor diagnosis. Hybridoma 15:49–53, 1996
   PubMed Web of Science ®Google Scholar
• Di Loreto C, Di Lauro V, Puglisi F et al: Immunocytochemical expression of tissue specific transcription factor-1 in lung car-cinoma. J Clin Pathol 50:30–2, 1997
   PubMed Web of Science ®Google Scholar
• Moll R, Wu XR, Lin JH, Sun TT: Uroplakins, specific mem-brane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol 147:1383–97, 1995
   PubMed Web of Science ®Google Scholar
• Wu RL, Osman I, Wu XR et al: Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder ep-ithelial differentiation and tumor formation. Cancer Res 58: 1291–7, 1998
   PubMed Web of Science ®Google Scholar
• Nadji M, Tabei Z, Castro A, Morales AR: Immunohistological demonstration of prostatic origin of malignant neoplasms [let-ter]. Lancet 1:671–2, 1979
   PubMed Web of Science ®Google Scholar
• Chang K, Pastan I, Willingham MC: Isolation and character-ization of a monoclonal antibody, Kl, reactive with ovarian cancers and normal mesothelium. Int J. Cancer 50:373–81, 1992
   PubMed Web of Science ®Google Scholar
• Nicholson AG, McCormick CJ, Shimosato Y et al: The value of PE-10, a monoclonal antibody against pulmonary surfac-tant, in distinguishing primary and metastatic lung tumors. Histopathology 27:57–60, 1995
   PubMed Web of Science ®Google Scholar
• Deamant FD, Pombo MT, Battifora H: Estrogen receptor im-munohistochemistry as a predictor of site of origin in meta-static breast cancer. Appl Immunohistochem 1:188–192, 1993
   Google Scholar
• Raab SS, Berg LC, Swanson PE, Wick MR: Adenocarcinoma in the lung in patients-with breast cancer. A prospective analy-sis of the discriminatory value of immunohistology. Am J Clin Pathol 100:27–35, 1993
   PubMed Web of Science ®Google Scholar
• Swanson PE, Mazoujian G, Mills SE et al: Immunoreactivity for estrogen receptor protein in sweat gland tumors. Am J Surg Pathol 15:835–41, 1991
   PubMed Web of Science ®Google Scholar
• Diaz NM, Mazoujian G, Wick MR: Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular ade-noma. Arch Pathol Lab Med 115:1203–7, 1991
   PubMed Web of Science ®Google Scholar
• Viale G, Doglioni C, Gambacorta M et al: Progesterone re-ceptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin. Cancer 70:2268–77, 1992
   PubMed Web of Science ®Google Scholar
• Bacchi CE, Garcia RL, Gown AM: Immunolocalization of estrogen and progesterone receptors in neuroendocrine tumors of the lung, skin, gastrointestinal and female genital tracts. Applied Immunohistochem 5:17–22, 1997
   Google Scholar